ResearcherMayo ClinicNo recent work listed

Benny Johnson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3683-8115; OpenAlex author ID A5010363210. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 2 papers

Papers 2

Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of panc… Co-author DOI 10.21037/jgo.2016.11.05 ↗
Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy. Co-author DOI 10.3978/j.issn.2078-6891.2015.091 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sandeep Bobby Reddy · 1 shared paper, 2016 · strength 0.08
- Paper Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted … DOI 10.3978/j.issn.2078-6891.2015.091 ↗
Alva Bowen Weir · 1 shared paper, 2016 · strength 0.07
- Paper Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression… DOI 10.21037/jgo.2016.11.05 ↗
Joseph Blansfield · 1 shared paper, 2016 · strength 0.07
- Paper Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression… DOI 10.21037/jgo.2016.11.05 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.